Association between AZD7442 (tixagevimab-cilgavimab) Administration and SARS-CoV-2 Infection, Hospitalization and Mortality
This activity is designed for anesthesiologists, anesthesiologists-in-training, anesthesia investigators, and allied health professionals who conduct research, practice, or intend to practice in any area of general anesthesia, subspecialty anesthesia, or pain management.
|After having completed this activity, you will be able to:|
The IARS makes every effort to develop CME activities that are independent, objective, scientifically balanced presentations of information. The IARS has implemented mechanisms requiring everyone in a position to control content to disclose all relevant financial relationships with commercial interests. Disclosure of any or no relationships is made available in advance of all educational activities.
The IARS evaluates the disclosures and, if necessary, resolves any conflicts of interest prior to the start of the activity. Individuals who refuse or fail to provide the required disclosures are disqualified from being a planning committee member, teacher, or author of CME, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity.
The planners, speakers, and others in a position to control content of this activity have disclosed no relevant financial relationships and have no conflicts of interest.
The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
No commercial support has been received for this activity.
|The International Anesthesia Research Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.|
Credit Designation Statement
The IARS designates this Journal-based CME Activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Maintenance Of Certification in Anesthesiology (MOCA®)|
|This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.|
After having completed the activity and its associated evaluations, you will need to claim credit by selecting the AMA PRA Category 1 Credit™ option. You will also have the opportunity to claim MOCA points. For physicians who select the MOCA option, this information will be transmitted automatically to the ACCME for verification of MOC points with the ABA.